People with type 2 diabetes can be at a higher risk for broken bones when they use weight-loss strategies
And to this day, we still actually follow the algorithm: If there was a history of pancreatitis, do not use. The concern stemmed from early case reports suggesting that patients developed pancreatitis while taking GLP-1 agonists
(Interestingly enough, the provider does not need to be enrolled in Medicare, but must not be on the Preclusion List.) How does the Bridge interact with Medicares existing GLP-1 coverage
Increasingly, for-profit telehealth companies are filling the void
Phase 4 - Maintenance Dose: 0.25 to 1.0 mg weekly
The dataset analyzed in this manuscript is derived from a frozen snapshot of the UKBB data, encompassing all available samples up to 31 January 2024, totaling n = 502,536